ASTEC
Astec Lifesciences Limited
Each stock's 10,000-path forecast, rendered as light.
Astec Lifesciences Limited (ASTEC) Stock Analysis & Case Study
Is ASTEC a good buy? The data-driven verdict.
Astec Lifesciences Limited (ASTEC) trades at ₹620,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 25/100.
On the numbers, Astec Lifesciences Limited (ASTEC) high-risk on the numbers, a Downstox Snapshot Score of 25/100, weighing expensive at 175.0× earnings, ROE of -25.2%, a 49% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
ASTEC fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How ASTEC ranks against the 2,373 companies in our screener
- ASTEC's market cap of 1,383 Cr ranks in the 45th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ASTEC's book value of ₹175 ranks in the 69th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ASTEC's promoter holding of 72.0% ranks in the 79th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ASTEC's 3-year profit (PAT) growth of -23.0% ranks in the 10th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ASTEC's 3-year revenue growth of -11.0% ranks in the 9th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ASTEC's debt-to-equity ratio of 1.15x is lower than 11% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is ASTEC overvalued? ASTEC P/E vs peers
ASTEC trades at 175.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
ASTEC share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of ASTEC history (5%/yr drift, 51%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ASTEC 2027 | ₹314 | ₹611 | ₹1,189 | -2% |
| ASTEC 2028 | ₹234 | ₹601 | ₹1,543 | -3% |
| ASTEC 2029 | ₹187 | ₹592 | ₹1,872 | -5% |
| ASTEC 2030 | ₹158 | ₹583 | ₹2,155 | -6% |
| ASTEC 2031 | ₹134 | ₹574 | ₹2,457 | -8% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ASTEC goes up, or doubles?
The bull case for ASTEC
- Astec Lifesciences Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,872.
The bear case & risks
- ASTEC's P/E of 175.0x is lower than 6% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ASTEC's Piotroski F-Score is 0/8. A screener percentile is not available for it right now.
- High historical volatility (51%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹187.
ASTEC volatility & expected range, how bumpy is the ride?
Over the last 9.8 years ASTEC compounded at 5%/year with annualized volatility of 51%. That volatility implies a 1-year 80% range of ₹314-₹1,189, the honest backbone behind any single price target.
ASTEC price forecast, the full 60-month probability fan
ASTEC price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ASTEC hits common targets within the simulated horizon?
Full multi-horizon detail on the ASTEC price target & forecast page.
ASTEC Piotroski F-Score: 0/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. ASTEC scores 0/8, weak on the financial-strength checks.
ASTEC MTF margin & leverage across 8 brokers
Margin Trading Facility lets you buy ASTEC with part of the capital. Lower margin % = higher leverage. Rates compared across 8 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 39.51% | 2.5× |
| Groww | 39.74% | 2.5× |
| Dhan | 40.00% | 2.5× |
| Paytm Money | 45.57% | 2.2× |
| Pocketful | 40.20% | 2.5× |
| Anand RathiCHEAPEST | 39.51% | 2.5× |
| Bajaj Broking | 45.00% | 2.2× |
| Share India | 39.74% | 2.5× |
Compare every broker on the ASTEC MTF page.
About Astec Lifesciences Limited: sector, index & market-cap context
Astec Lifesciences Limited (ASTEC) is a small-cap NSE-listed company, with a market capitalisation of ₹1,383 Cr. See more stocks on our screener.
How the ASTEC Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Astec Lifesciences Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ASTEC analysis, FAQs
Is Astec Lifesciences Limited (ASTEC) a good buy?
On the numbers, Astec Lifesciences Limited (ASTEC) high-risk on the numbers, a Downstox Snapshot Score of 25/100, weighing expensive at 175.0× earnings, ROE of -25.2%, a 49% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ASTEC overvalued or undervalued?
ASTEC trades at 175.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the ASTEC share price target for 2031?
ASTEC's probability-weighted 2031 median target is ₹574, with an 80% range of ₹134-₹2,457 (10,000-path Monte-Carlo).
What is the probability ASTEC doubles in 5 years?
The modelled probability of ASTEC reaching ₹1,241 (2×) within 5 years is 25%.
What is the bull case for ASTEC?
Astec Lifesciences Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in ASTEC?
ASTEC's P/E of 175.0x is lower than 6% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. ASTEC's Piotroski F-Score is 0/8. A screener percentile is not available for it right now. High historical volatility (51%/yr) means a wide, bumpy range of outcomes, size positions accordingly.